Related Experiment Videos
Access to specialist cancer care: is it equitable?
E Pitchforth1, E Russell, M Van der Pol
1Department of Public Health, University of Aberdeen, Aberdeen, UK. e.pitchforth@abdn.ac.uk
British Journal of Cancer
|November 20, 2002
Summary
Patients with colorectal cancer admitted to non-specialist hospitals received chemotherapy less often. This suggests disparities in cancer care access, highlighting the need for equitable chemotherapy provision across all hospital types.
Area of Science:
- Oncology
- Health Services Research
- Public Health
Background:
- The Calman-Hine report advocated for uniform high-quality cancer care access for all patients.
- Variations in healthcare access and quality can disproportionately affect patient outcomes.
- Understanding chemotherapy uptake by hospital type is crucial for assessing equitable cancer care delivery.
Purpose of the Study:
- To evaluate if chemotherapy uptake for colorectal cancer differs based on hospital specialization in Scotland.
- To establish a baseline for monitoring access to specialist cancer care following the Calman-Hine recommendations.
Main Methods:
- Hospitals were categorized into 'cancer centres', 'cancer units', and 'non-cancer' hospitals based on specialization.
- Colorectal cancer patient data (1992-1996) were sourced from cancer registrations and hospital discharge records.
- Multilevel logistic regression analyzed chemotherapy receipt within six months of initial hospital admission.
Main Results:
- Patients initially admitted to 'non-cancer' hospitals were less than half as likely to receive chemotherapy (OR=0.28) compared to those in 'cancer units' or 'cancer centres'.
- This disparity was not attributable to geographical distance to a cancer centre, patient age, or illness severity.
- The findings indicate a significant difference in chemotherapy access based on the type of hospital where patients first received care.
Conclusions:
- Initial hospital admission type significantly impacts chemotherapy uptake for colorectal cancer patients.
- Patients treated at non-specialist hospitals face barriers to receiving timely chemotherapy.
- This study underscores the importance of equitable resource allocation and specialist access to ensure consistent cancer care quality across all healthcare facilities.